首页> European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology> Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study.

Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study.

导出 OA

翻译打印收藏纠错

第一作者： Alessandra,Oliva

第一单位： Department of Public Health and Infectious Diseases, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, 00185, Italy. alessandra.oliva@uniroma1.it.

作者： Alessandra,Oliva ^[1] ; L,Liguori ^[2] ; S,Covino ^[2] ; F,Petrucci ^[2] ; F,Cogliati-Dezza ^[2] ; A,Curtolo ^[2] ; G,Savelloni ^[2] ; M,Comi ^[2] ; F,Sacco ^[3] ; G,Ceccarelli ^[2] ; A,Viscido ^[3] ; F,Alessandri ^[4] ; G,Raponi ^[3] ; F,Pugliese ^[4] ; C M,Mastroianni ^[2] ; M,Venditti ^[2]

作者单位： Department of Public Health and Infectious Diseases, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, 00185, Italy. alessandra.oliva@uniroma1.it. ^[1] Department of Public Health and Infectious Diseases, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, 00185, Italy. ^[2] Microbiology and Virology Laboratory, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. ^[3] Department of General and Specialistic Surgery, Sapienza University of Rome, Rome, Italy. ^[4]

关键词 Bloodstream infection Carbapenem-resistant Acinetobacter baumannii Cefiderocol Colistin Pneumonia Ventilator-acquired pneumonia